Documents tagged "Shot"
Found 4 documents with this tag
EFTA00004250-p-17.jpg
The image shows a strip of film with six exposures. Each frame contains an identical photograph of what appears to be a cloud formation against a blue sky. The film has markings that indicate the sequence and details of each shot, such as 'Shot Number', 'Shutter Speed', 'Aperture', and other technical information typically found on photographic film strips. This suggests that the images were taken systematically under controlled conditions, possibly for scientific or meteorological purposes. There are no visible texts, people, or distinct locations in any of the individual shots; all focus is solely on the cloud formations.
DOJ-OGR-00026798.jpg
The image appears to be a photograph of an official document. At the top left corner, there is a logo followed by the name "Metropolitan Correctional Center New York NY". Below this heading, there's a section titled "Photo Shot Sheet" with several lines of text, possibly indicating instructions or information related to photographs taken within the facility. The document has various fields and checkboxes filled out in black ink. There is also a handwritten note in the bottom right corner that says "Approved" along with what seems like a signature, suggesting that this document has been reviewed and sanctioned by an authority figure.
HOUSE_OVERSIGHT_026362.txt
The FDA has approved Praluent, a new cholesterol-lowering medicine for people with established heart disease whose risk is not adequately controlled by existing statin drugs. It is administered through an injection and its long-term effects are unknown. The approval of this drug marks a significant advancement in the battle against heart disease, particularly for patients who have been difficult to treat due to high levels of LDL cholesterol. However, the new drug's cost may pose financial challenges down the line.
HOUSE_OVERSIGHT_025888.txt
This document discusses the FDA approval of a new cholesterol-lowering drug called Praluent, which is manufactured by Regeneron Pharmaceuticals. The article highlights the potential benefits and costs associated with this medication, as well as its impact on the battle against heart disease. Notable individuals mentioned in the document include Sultan Bin Sulayem, Jeffrey Epstein, Forbes Staff writer Matthew Herper, and Steven Nissen of the Cleveland Clinic.